Global Health EDCTP3 RIA Calls, Second Stage (Invited Consortia)
Global Health EDCTP3 Joint Undertaking
Consortia successful at the 4 March 2026 first stage on TB drugs, lower respiratory tract infections, HIV co-infections, and climate & health. Second stage by invitation only.
Verification date not recorded
Closing time and timezone not stated.
At a glance
- Funding / main benefit
- €5M-€10M per project; €147M total work programme
- Deadline
- 17 September 2026
- Duration
- Not stated
- Location / format
- Not stated
- Career stage
- Not stated
- Geographic eligibility
- Not stated
Is this for me?
Best suited to: Consortia successful at the 4 March 2026 first stage on TB drugs, lower respiratory tract infections, HIV co-infections, and climate & health. Second stage by invitation only.
Uganda relevance: Uganda-specific eligibility is not confirmed. Check the funder's nationality, residence and affiliation rules.
What the opportunity provides
- €5M-€10M per project; €147M total work programme
€5M-€10M per project; €147M total work programme
Eligibility checklist
- Consortia successful at the 4 March 2026 first stage on TB drugs, lower respiratory tract infections, HIV co-infections, and climate & health. Second stage by invitation only.
Sources and verification
Verification date not recorded.
Related open opportunities
Get the next relevant opportunity
Receive newly verified grants, scholarships and fellowships from Methods Bench.